A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Treatment Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering products of unknown origin.
Several professionals stated the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Material Elimination
Based on the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.
Digital Trading Operations
Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, positive reviews and detailed guides for mixing or administering at home.
After moments of entering one group, a seller shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Product Information and Pricing
Within these communities, posts display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to possibly serious health risks”.
